Ablative Solutions takes in $77 mln Series D
Kalamazoo, Michigan and San Jose, California-based Ablative Solutions Inc, a company focused on treating hypertension, has secured $77 million in Series D funding. Gilde Healthcare and BioStar Ventures led the round with participation from other investors that included Michigan Accelerator Fund and Novus Biotechnology.
3 January 2019•1 min read
